Edgewise Therapeutics Logo

Edgewise, EWTX and Stifel

Edgewise Therapeutics, Inc. (NASDAQ:EWTX) Short Interest Up 8.9% in December

Edgewise Therapeutics, Inc. (NASDAQ:EWTX – Get Free Report) was the target of a significant growth in short interest during the month of December. As of December 31st, there was short interest totalling 6,

Business Insider · 1d

Edgewise Therapeutics initiated with a Hold at Stifel

Stifel initiated coverage of Edgewise Therapeutics (EWTX) with a Hold rating and $30 price target The firm says that while Edgewise has “very

Fintel on MSN · 1d

Stifel Initiates Coverage of Edgewise Therapeutics (EWTX) with Hold Recommendation

Fintel reports that on January 22, 2025, Stifel initiated coverage of Edgewise Therapeutics (NasdaqGS:EWTX) with a Hold recommendation. Analyst Price Forecast Suggests 84.07% Upside As of December 23,

Investing.com on MSN · 1d

Stifel initiates Edgewise Therapeutics stock with Hold rating, $30 target

Stifel analysts began coverage of Edgewise Therapeutics (NASDAQ:EWTX), currently valued at $2.6 billion, with a Hold rating and set a price target of $30.00. According to InvestingPro data, the stock trades at $27.

22hon MSN

Edgewise Therapeutics names new COO

Edgewise Therapeutics , Inc., a biotechnology company specializing in pharmaceutical preparations, announced the promotion of ...

Edgewise Therapeutics promotes Behrad Derakhshan to COO

Edgewise Therapeutics (EWTX) announced changes to its executive team. These changes include the addition of Robert Blaustein, joining the ...

Yahoo Finance6d

Edgewise Therapeutics (NASDAQ:EWTX) Is In A Good Position To Deliver On Growth Plans

For example, Edgewise Therapeutics (NASDAQ:EWTX) shareholders have done very well over the last year, with the share price soaring by 176%. Having said that, unprofitable companies are risky ...

1don MSN

Edgewise Therapeutics reshuffles executive team

BOULDER, Colo. - Edgewise Therapeutics Inc. (NASDAQ:EWTX), a biopharmaceutical company focused on muscle disease treatment ...

Business Wire10d

Edgewise Therapeutics Provides Corporate Update and Highlights Priorities for 2025

BOULDER, Colo.--(BUSINESS WIRE)--Edgewise Therapeutics, Inc. (Nasdaq: EWTX), a leading muscle disease biopharmaceutical company, today provided recent corporate updates and highlighted upcoming ...

Yahoo Finance2mon

Edgewise Therapeutics, Inc. (EWTX)

BOULDER, Colo., January 13, 2025--Edgewise Therapeutics, Inc. (Nasdaq: EWTX), a leading muscle disease biopharmaceutical company, today provided recent corporate updates and highlighted upcoming ...

Results that may be inaccessible to you are currently showing.

Hide inaccessible results